INS and gestational diabetes: The results showed that exogenous insulin therapy could promote the phosphorylation of placental insulin mediators by activating the insulin cascade in women with GDM receiving insulin treatment, thereby elevating specific fatty acid carriers and ultimately contributing to increased fatty acid levels in the placenta [69].